Anthony V. Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M. Boer, Monique L. den Boer, Rob Pieters, Valerie de Haas, Martin A. Horstmann, Gabriele Escherich, Bertil Johansson, Hanne V. Marquart, Kjeld Schmiegelow, Jeremy Hancock, John Moppett, Mats Heyman
{"title":"整合遗传学和 MRD,以确定在诱导治疗结束时具有中等 MRD 水平的低风险 B 细胞前体急性淋巴细胞白血病患者。","authors":"Anthony V. Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M. Boer, Monique L. den Boer, Rob Pieters, Valerie de Haas, Martin A. Horstmann, Gabriele Escherich, Bertil Johansson, Hanne V. Marquart, Kjeld Schmiegelow, Jeremy Hancock, John Moppett, Mats Heyman","doi":"10.1038/s41375-024-02329-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18109,"journal":{"name":"Leukemia","volume":null,"pages":null},"PeriodicalIF":12.8000,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41375-024-02329-0.pdf","citationCount":"0","resultStr":"{\"title\":\"Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction\",\"authors\":\"Anthony V. Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M. Boer, Monique L. den Boer, Rob Pieters, Valerie de Haas, Martin A. Horstmann, Gabriele Escherich, Bertil Johansson, Hanne V. Marquart, Kjeld Schmiegelow, Jeremy Hancock, John Moppett, Mats Heyman\",\"doi\":\"10.1038/s41375-024-02329-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18109,\"journal\":{\"name\":\"Leukemia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":12.8000,\"publicationDate\":\"2024-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.nature.com/articles/s41375-024-02329-0.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Leukemia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41375-024-02329-0\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41375-024-02329-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction
期刊介绍:
Title: Leukemia
Journal Overview:
Publishes high-quality, peer-reviewed research
Covers all aspects of research and treatment of leukemia and allied diseases
Includes studies of normal hemopoiesis due to comparative relevance
Topics of Interest:
Oncogenes
Growth factors
Stem cells
Leukemia genomics
Cell cycle
Signal transduction
Molecular targets for therapy
And more
Content Types:
Original research articles
Reviews
Letters
Correspondence
Comments elaborating on significant advances and covering topical issues